Cost-Utility Analysis of Varenicline Versus Existing Smoking Cessation Strategies in Korea
Value Health
.
2014 Nov;17(7):A726.
doi: 10.1016/j.jval.2014.08.053.
Epub 2014 Oct 26.
Authors
D J Park
1
,
Y H Kim
2
,
E J Kim
3
Affiliations
1
Pfizer Pharmaceuticals Korea Ltd., Seoul, South Korea.
2
Seoul National University, Seoul, South Korea.
3
Graduate School of Public Health, Seoul National University, Seoul, South Korea.
PMID:
27202584
DOI:
10.1016/j.jval.2014.08.053
No abstract available